Pre Market
|
||||
|
|
|
|
Regular Hours
|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
| Valuation Estimation |
|
EPS (Current/Estimated)
-4.46/-4.06
|
|
Enterprise Value
40.25M
|
| Balance Sheet |
|
Book Value Per Share
4.90
|
| Cash Flow |
|
Cash Flow Yield
--
|
| Income Statement |
|
Total Revenue
0
|
|
Operating Revenue Per Share
--
|
|
Industry Comparison
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quotes are at least 15-min delayed:2025/11/20 06:32 EST
Industry overview quotes are at least 15 minutes delayed
|
Business Description
|
|||
| OnKure Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing top-tier precision medicines that target biologically validated drivers of cancers that are underserved by available therapies. Thecompany operates in one operating segment which is clinical research. |

-- 

2.76